TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients
Clinical trial NCT00412646 · COMPLETED
Trial details
- NCT number
- NCT00412646
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.